Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Gross Profit: 2018-2024

Historic Gross Profit for Burning Rock Biotech (BNR) over the last 7 years, with Dec 2024 value amounting to $49.6 million.

  • Burning Rock Biotech's Gross Profit fell 14.43% to -$162.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.5 million, marking a year-over-year increase of 170.48%. This contributed to the annual value of $49.6 million for FY2024, which is 2.96% down from last year.
  • Burning Rock Biotech's Gross Profit amounted to $49.6 million in FY2024, which was down 2.96% from $51.2 million recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Gross Profit registered a high of $57.1 million during FY2021, and its lowest value of $48.1 million during FY2020.
  • Over the past 3 years, Burning Rock Biotech's median Gross Profit value was $51.2 million (recorded in 2023), while the average stood at $52.0 million.
  • As far as peak fluctuations go, Burning Rock Biotech's Gross Profit rose by 21.53% in 2020, and later decreased by 7.15% in 2023.
  • Over the past 5 years, Burning Rock Biotech's Gross Profit (Yearly) stood at $48.1 million in 2020, then increased by 18.77% to $57.1 million in 2021, then declined by 3.57% to $55.1 million in 2022, then dropped by 7.15% to $51.2 million in 2023, then declined by 2.96% to $49.6 million in 2024.